Omnicell Appoints Bruce Smith to Board of Directors

Advocate Health Care senior vice president of information systems and CIO brings decades of experience in evolving care delivery

April 16, 2014

Mountain View, Calif.

Omnicell Inc., (NASDAQ: OMCL) today announced the appointment of Bruce D. Smith, senior vice president of information systems and CIO for Advocate Health Care, to its board of directors. With more than 25 years of health IT experience, Mr. Smith brings a unique understanding of the technology challenges facing today’s hospitals and health systems.

 “Bruce brings a distinctive mix of executive leadership and technical savvy in a healthcare setting that makes him an excellent addition to the Omnicell board,” said Randall Lipps, Omnicell president, chairman and CEO. “As Omnicell’s health system customers serve an increasingly broad continuum of care, even extending beyond the hospital, Bruce’s depth of knowledge gained by supporting enterprise-wide provider workflows to improve patient outcomes at Advocate Health Care will be invaluable to our company. “

With a staff of 500 and an operating budget of $130 million, Mr. Smith’s division supports a network of financial and clinical applications that have been integrated to share information throughout the Advocate system. Previously, Mr. Smith was Vice President and Chief Information Officer for Lutheran General HealthSystem. He began his career with Sears, where he became involved in the development of computer programs in the merchandising division.  

Mr. Smith is a member of Health Information Management Systems Society (HIMSS), the HIMSS Chicago CIO Roundtable and the Scottsdale Institute, a healthcare executive resource for information management. He received his Bachelor of Business degree from Western Illinois University and his M.B.A. from Loyola University Chicago.

Omnicell also acknowledged the contributions of director Donald Wegmiller, chairman emeritus of Integrated Healthcare Strategies, who is departing the board following ten years of service during a period of Omnicell’s rapid growth. These changes to the Omnicell board are effective immediately prior to Omnicell’s Annual Meeting of Stockholders.

 “As we welcome Bruce, we are also saying goodbye to an excellent board member and healthcare icon. It has been one of the greatest pleasures of my career to work with Don over the past ten years. His operational and industry expertise has been invaluable to Omnicell’s growth and contributed to the position of innovative leadership we have attained. I want to thank him for his service and contributions as our lead independent director,” said Mr. Lipps.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum— from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.

More than 2,800 Acute Care customers worldwide have utilized Omnicell’s medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.